---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-032118"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2023-09-13T23:59:59+00:00"
generated_at: "2026-06-10T19:17:50.779203+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BeautyHealth launches cost-cutting program targeting $35M+ annual savings, $100M buyback

## Summary
- Phase 1 expected to generate >$20M annualized cost savings in Q1 2024; Phase 2 >$15M in Q2 2024.
- Board authorized $100M share repurchase program; funded from existing cash, via Rule 10b5-1 plan in Q3 2023.
- Company re-affirms 2025 guidance: $600-$700M net sales, up to 500 bps gross margin expansion vs FY2021, 25-30% EBITDA margin.
- Cost reductions from streamlining go-to-market, process automation, and manufacturing efficiencies; no large M&A anticipated.
- Update on transformation program expected during Q3 2023 earnings call in November 2023.

## SEC filing metadata
- accession: 0001628280-23-032118
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2023-09-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828023032118/0001628280-23-032118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828023032118/skin-20230912.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-032118
- JSON: https://secwatch.observer/filing/0001628280-23-032118.json
- Plain text: https://secwatch.observer/filing/0001628280-23-032118.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.